Indapres (Indapamide)

Indapamide works by blocking the sodium‑chloride cotransporter in the distal convoluted tubule of the kidney. This inhibition reduces sodium reabsorption, leading to increased urinary loss of sodium and water. The resulting decrease in blood volume, together with a modest direct vasodilatory effect on blood vessels, lowers arterial pressure.

The appropriate dose of Indapres is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other medications. Dosage adjustments may be required for renal function, age, or concomitant drugs, and the prescriber will provide specific instructions.

The safety of indapamide during pregnancy or lactation has not been definitively established. It should only be used if the potential benefit justifies the possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider after a careful risk‑benefit assessment.

To request Indapres, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Indapamide belongs to the thiazide‑like class, offering a longer duration of action and a lower incidence of metabolic disturbances compared with many conventional thiazides. It provides effective blood‑pressure control and diuresis while often requiring lower doses, but individual response varies, and clinicians choose the agent that best fits the patient’s overall profile.

Indapres tablets should be stored at ambient temperature below 25 °C, in their original packaging, protected from moisture and direct light. Keep the product out of reach of children and avoid storing in bathrooms or other humid environments to maintain stability and potency.

Indapres is taken orally, usually with a glass of water. It may be taken with or without food, as directed by the prescriber. Patients should follow the dosing schedule provided by their healthcare professional and should not alter the dose or frequency without medical advice.

Serious risks include severe dehydration, marked low blood pressure (hypotension), electrolyte disturbances such as low potassium or sodium, and rare allergic reactions like rash, angioedema, or blood‑cell abnormalities. Patients should seek immediate medical attention if they experience fainting, rapid heartbeat, swelling of the face or throat, or unusual bruising or bleeding.

Indapres is contraindicated in individuals with known hypersensitivity to indapamide or other sulfonamide diuretics, in patients with anuria (absence of urine production), and in those with severe electrolyte imbalances that have not been corrected. Caution is also advised for patients with severe liver disease, uncontrolled diabetes, or those taking interacting medications without supervision.